IP Library Granted Patent US 7,335,770
Granted Patent B2
US 7,335,770 · App. 10/808,210 · Granted Feb 26, 2008

Triazine compounds and their analogs, compositions, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,335,770
App. No.
10/808,210
Granted
Feb 26, 2008
Kind
B2
Abstract

The present invention relates to triazine compounds and their analogs and derivatives, and methods and compositions comprising these compounds. The compounds and compositions of this invention are useful for, among other things, treating pathophysiological conditions arising from inflammatory responses, inhibiting or blocking glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells, inhibiting smooth muscle proliferation, treating vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis, and the like.

Claims (48)

1. A compound selected from:

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-[2-(2-fluoro-phenoxy)-ethoxy]-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(1-methyl-pyrrolidin-2-ylmethoxy)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(1-methyl-piperidin-4-yloxy)-[1,3,5]triazine-2,4-diamine;

3-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-2-ethyl-pyran-4-one;

1-{3-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-piperidin-1-yl}-ethanone;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-isopropoxy-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(2-fluoro-phenoxy)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(6-methyl-pyridin-2-yloxy)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(4-iodo-phenoxy)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(2-iodo-phenoxy)-[1,3,5]triazine-2,4-diamine;

4-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-phenyl}-2-methyl-but-3-yn-2-ol;

4-{2-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-phenyl}-2-methyl-but-3-yn-2-ol;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(pyridin-3-yloxy)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(1-ethyl-piperidin-3-yloxy)-[1,3,5]triazine-2,4-diamine;

4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-benzaldehyde;

3-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-phenyl}-acrylic acid ethyl ester;

1-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-phenyl}-ethanone;

4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-benzaldehyde oxime;

1-{3-Chloro-4-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-phenyl}-ethanone;

4-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-isopropylamino-[1,3,5]triazin-2-yloxy]-phenyl}-2-methyl-but-3-yn-2-ol;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-phenylsulfanyl-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(2-methoxy-phenylsulfanyl)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(4-fluoro-phenylsulfanyl)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(2,6-dichloro-phenylsulfanyl)-[1,3,5]triazine-2,4-diamine;

6-(2-tert-Butyl-phenylsulfanyl)-N-(3-chloro-4-methoxy-phenyl)-N′-cycloheptyl-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(2,4-dimethoxy-phenyl)-[1,3,5]triazine-2,4-diamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(2,4,6-trimethoxy-phenyl)-[1,3,5]triazine-2,4-diamine;

4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-benzene-1,3-diol;

1-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-naphthalen-2-ol;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-6-(tetrahydro-furan-2-ylmethoxy)-[1,3,5]triazine-2,4-diamine;

4-{4-Cycloheptylamino-6-[(1-ethyl-pyrrolidin-2-ylmethyl)-amino]-[1,3,5]triazin-2-ylamino}-cyclohexanol;

N-Cycloheptyl-N′-(1-ethyl-pyrrolidin-2-ylmethyl)-N″-(3-fluoro-4-methyl-phenyl)-[1,3,5]triazine-2,4,6-triamine;

N-Cycloheptyl-N′-(3-fluoro-4-methyl-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine;

N-Cycloheptyl-N′-methyl-N′-(1-methyl-piperidin-4-yl)-N″-(3-nitro-phenyl)-[1,3,5]triazine-2,4,6-triamine;

N-Cycloheptyl-N′-(3-fluoro-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine;

N-(4-Benzyloxy-3-chloro-phenyl)-N′-cycloheptyl-N″-(1-ethyl-pyrrolidin-2-ylmethyl)-[1,3,5]triazine-2,4,6-triamine;

N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(tetrahydro-furan-2-ylmethyl)-[1,3,5]triazine-2,4,6-triamine;

2,4,6-Tris-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine;

{2-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-ethyl}-carbamic acid tert-butyl ester;

N-Cycloheptyl-6-ethoxy-N′-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4-diamine;

N-(2-Amino-ethyl)-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-[1,3,5]triazine-2,4,6-triamine;

4-(5-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-piperidin-1-yl}-5-oxo-pentyl)-tetrahydro-thieno[3,4-d]imidazol-2-one;

5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoic acid {5-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-pentyl}-amide;

5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoic acid N′-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-hydrazide;

5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoic acid {2,-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-ethyl}-amide;

2-{4-[4-[(1-Ethyl-pyrrolidin-2-ylmethyl)-amino]-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-piperazin-1-yl}-1-pyrrolidin-1-yl-ethanone; or

2-{4-[4-[(1-Ethyl-pyrrolidin-2-ylmethyl)-amino]-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5triazin-2-yl]-piperazin-1-yl}-1-pyrrolidin-1-yl-ethanone dihydrogen chloride salt.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE RECEIVING PARTY AS LISTED ON THE PATENT ASSIGNMENT COVER SHEET ATTACHED HERETO AND PREVIOUSLY RECORDED ON REEL 023985 FRAME 0502. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ADDRESS OF THE RECEIVING PARTY IS 7-1-27, AMEERPET, HYDERABAD-500016, INDIA.. Recorded Jul 6, 2010
From: REDDY US THERAPEUTICS, INC.
To: DR. REDDY'S LABORATORIES LTD.
Reel/Frame 024630/0384 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2010
From: REDDY US THERAPEUTICS, INC.
To: DR. REDDY'S LABORATORIES LTD.
Reel/Frame 023985/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2006
From: TIMMER, RICHARD T.; ALEXANDER, CHRISTOPHER W.; PILLARISETTI, SIVARAM; SAXENA, UDAY; ALLURI, SESHA SRIDEVI; REDDY, VELAGALA VENKATA RAMA MURALI KRISHNA; PAL, MANOJIT; REDDY, JANGALGAR TIRUPATHY; YELESWARAPU, KOTEWAR RAO; REDDY, GADDAM OM; KUMAR, POTLAPALLY REJENDER
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 018349/0364 →